LSP1 and glioblastoma: Since these malignant biological behaviors have been reported to contribute to radiotherapy and chemotherapy resistance [35], we employed multivariate Cox regression and survival analyses to examine whether LSP1 could serve as a marker for the prediction of the response to radiotherapy and chemotherapy in GBM patients.